Trial intelligence / Profile preview

SAMe for Reducing AFP in Hepatitis C Patients

NCT00513461Phase 2Completed

Sponsor
Chao Family Comprehensive Cancer Center
Start
Oct 2007
Primary completion
Aug 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of S-adenosylmethionine in hepatocellular carcinoma (HCC), sponsored by Chao Family Comprehensive Cancer Center. Started Oct 2007; status: completed.

02

Drugs

S-adenosylmethionine
03

Conditions

hepatocellular carcinoma (HCC)

Beyond the preview

Go deeper on NCT00513461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00513461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call